Trial Profile
Study to evaluate the population PK of cefazolin in non-obese, obese and morbidly obese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2018
Price :
$35
*
At a glance
- Drugs Cefazolin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 28 Mar 2018 New trial record
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.